The document summarizes a report on Fusilev API Insight from 2020. The report provides details on Fusilev manufacturers across the US, Europe, China and India. It includes information on Fusilev's mechanism of action, regulatory approvals, clinical trials, patents, historical and forecasted sales through 2022. It also highlights competing therapies and emerging treatments in Fusilev's area. The data comes from DelveInsight's internal databases and primary/secondary research sources.